As LAM is the main pulmonary manifestation in female TSC patients [3] and because TSC2-/meth cells can efficiently migrate in the dermal tissue (Figure 1a), we investigated the capability of TSC2-/meth to reach the lung parenchyma. The gene discussed is TSC2; the disease is lymphangioleiomyomatosis.